oru.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Targeted Analysis of Serum Proteins Encoded at Known Inflammatory Bowel Disease Risk Loci
Affinity Proteomics, SciLifeLab, School of Biotechnology, KTH, Royal Institute of Technology, Stockholm, Sweden.
Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
Affinity Proteomics, SciLifeLab, School of Biotechnology, KTH, Royal Institute of Technology, Stockholm, Sweden.
Affinity Proteomics, SciLifeLab, School of Biotechnology, KTH, Royal Institute of Technology, Stockholm, Sweden.
Visa övriga samt affilieringar
2019 (Engelska)Ingår i: Inflammatory Bowel Diseases, ISSN 1078-0998, E-ISSN 1536-4844, Vol. 25, nr 2, s. 306-316Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background: Few studies have investigated the blood proteome of inflammatory bowel disease (IBD). We characterized the serum abundance of proteins encoded at 163 known IBD risk loci and tested these proteins for their biomarker discovery potential.

Methods: Based on the Human Protein Atlas (HPA) antibody availability, 218 proteins from genes mapping at 163 IBD risk loci were selected. Targeted serum protein profiles from 49 Crohn's disease (CD) patients, 51 ulcerative colitis (UC) patients, and 50 sex- and age-matched healthy individuals were obtained using multiplexed antibody suspension bead array assays. Differences in relative serum abundance levels between disease groups and controls were examined. Replication was attempted for CD-UC comparisons (including disease subtypes) by including 64 additional patients (33 CD and 31 UC). Antibodies targeting a potentially novel risk protein were validated by paired antibodies, Western blot, immuno-capture mass spectrometry, and epitope mapping.

Results: By univariate analysis, 13 proteins mostly related to neutrophil, T-cell, and B-cell activation and function were differentially expressed in IBD patients vs healthy controls, 3 in CD patients vs healthy controls and 2 in UC patients vs healthy controls (q < 0.01). Multivariate analyses further differentiated disease groups from healthy controls and CD subtypes from UC (P < 0.05). Extended characterization of an antibody targeting a novel, discriminative serum marker, the laccase (multicopper oxidoreductase) domain containing 1 (LACC1) protein, provided evidence for antibody on-target specificity.

Conclusions: Using affinity proteomics, we identified a set of IBD-associated serum proteins encoded at IBD risk loci. These candidate proteins hold the potential to be exploited as diagnostic biomarkers of IBD.

Ort, förlag, år, upplaga, sidor
Oxford University Press, 2019. Vol. 25, nr 2, s. 306-316
Nyckelord [en]
inflammatory bowel disease, affinity proteomics, LACC1
Nationell ämneskategori
Gastroenterologi Immunologi inom det medicinska området
Identifikatorer
URN: urn:nbn:se:oru:diva-69892DOI: 10.1093/ibd/izy326ISI: 000462580900020PubMedID: 30358838Scopus ID: 2-s2.0-85059799081OAI: oai:DiVA.org:oru-69892DiVA, id: diva2:1261149
Forskningsfinansiär
Vetenskapsrådet, 2013-3862 2011-2764Knut och Alice Wallenbergs StiftelseKK-stiftelsen
Anmärkning

Funding Agencies:

AstraZeneca (Translational Research Program "Post-genomic applications in IBD: exploitation of genetic information toward improved diagnosis and therapy")

Örebro University Hospital Research Foundation  

Swedish Government (CancerUU)  

Science for Life Laboratory Stockholm  

KTH Center for Applied Precision Medicine (KCAP) - Erling-Persson Family Foundation

Tillgänglig från: 2018-11-06 Skapad: 2018-11-06 Senast uppdaterad: 2019-06-19Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMedScopus

Personposter BETA

Repsilber, DirkHalfvarson, Jonas

Sök vidare i DiVA

Av författaren/redaktören
Repsilber, DirkHalfvarson, Jonas
Av organisationen
Institutionen för medicinska vetenskaper
I samma tidskrift
Inflammatory Bowel Diseases
GastroenterologiImmunologi inom det medicinska området

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 180 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf